re: Ann: Completion of Rights Issue and Notic... tj,
I wish CEO would say something different. Its like a cut and paste.
Here is my version
"We've partered withwho is providing $2 billion up front with 20% of royalty agreement until 2023. The FDA advises that Nadolol and Zafirlukast inhaled forms have been expidited to market, following a relaxation of FDA rules for drugs with a known safety profile. " said CEO Twigman.
;)))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.010(8.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.5¢ | 12.5¢ | $7.727K | 57.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 185532 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 23633 | 1 |
View Market Depth
| Last trade - 10.01am 23/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |